Moreover, as the key node of IRAK1/TRAF6/NF-κB signaling, IRAK1 is rarely investigated in terms of screening of natural compounds for potential inhibitors and signaling suppressors to be used in the targeted therapy of hepatocellular carcinoma. Here, IRAK1 is linked to hepatocellular carcinoma.